Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 25, which means every article in Journal of Pharmacovigilance has got 25 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacovigilance.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Total published articles

31 57 61 61 17 5 26 31 56 62 50 30

Research, Review articles and Editorials

0 1 8 27 11 5 16 25 46 45 36 26

Research communications, Review communications, Editorial communications, Case reports and Commentary

31 56 53 34 6 0 10 6 10 17 14 4

Conference proceedings

0 7 0 0 0 0 30 50 94 70 201 73

Citations received as per Google Scholar, other indexing platforms and portals

151 216 237 311 270 254 238 198 319 91 48 18
Journal total citations count 2408
Journal impact factor 1.71
Journal 5 years impact factor 1.79
Journal cite score 12.14
Journal h-index 25
Important citations

Kaur M, Kosey S, Mehra N, Kumar R (2015) KNOWLEDGE AND AWARENESS OF ADVERSE DRUG REACTIONS. International Journal of Pharmaceutical Sciences and Research 6: 4601.

Li L, Wang J, Zang H, Zhang H, Jiang W,et al. (2016) Qualitative and Quantitative Analysis of Heparin during Precipitation by Near-Infrared Spectroscopy Res Rev: J Pharm Pharmaceut Sci 5: 39-45.

Qassim S, Metwali Z, Al Hariri Y (2016) WHY THERE IS A NEED FOR DRUG POST MARKETING SURVEILLANCE?. EJPMR 3: 45-50.

Azhar Hussain, Madeeha Malik, Sardar Shabbir (2016) EVOLVING TRENDS IN PHARMACOVIGILANCE AND MEDICINE SAFETY SYSTEM: A LITERATURE REVIEW. IAJPS 3: 1404-1414.

Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J (2016) Knowledge, Attitude and Practices of Pharmacovigilance and Adverse Drug Reaction Reporting among Pharmacists Working in Secondary and Tertiary Governmental Hospitals in Kuwait. Saudi Pharmaceutical Journal.

Gurmesa LT, Dedefo MG (2016) Factors Affecting Adverse Drug Reaction Reporting of Healthcare Professionals and Their Knowledge, Attitude, and Practice towards ADR Reporting in Nekemte Town, West Ethiopia. BioMed Research International.

Tatiparthi R, Mamo Y (2014) Prevalence of ADRs and Associated Factors of Anti retroviral Treatment on HIV Positive Adults at Jush. Indian Journal of Pharmacy Practice 7: 9.

Reis CD, Veiga CE, Martins JJ (2016) Pharmacovigilance in Cabo Verde: Measuring the Awareness and Knowledge of Consumers. J Pharmacovigil 4: 1-3.

Kalaivani M, Kalaiselvan V, Dabhi K, Singh GN (2015) Direct consumer reporting of ADRs to PvPI, a position paper of Indian pharmacopoeia commission. Adv Pharmacoepidemiol Drug Saf 4: 2167-1052.

Amarendra KE (2016) Overview of Pharmacovigilance. Res Rev: J Pharmacol Toxicol Stud 4:125-133.

Amarendra KE (2016) Overview of Pharmacovigilance. J Pharmacol Toxicol Stu 4: 125-133.

Li L, Wang J, Zang H, Zhang H, Jiang W, et al. (2016) Qualitative and Quantitative Analysis of Heparin during Precipitation by Near-Infrared Spectroscopy. Res Rev: J Pharm Pharmaceut Sci 5:39-45.

Nwaiwu O, Oyelade O, Eze C (2016) Evaluation of Pharmacovigilance Practice in Pharmaceutical Companies in Nigeria. Pharmaceutical Medicine 30: 291-295.

Azhar Hussain, Madeeha Malik, Sardar Shabbir (2016) EVOLVING TRENDS IN PHARMACOVIGILANCE AND MEDICINE SAFETY SYSTEM: A LITERATURE REVIEW. IAJPS 3: 1404-1414.

Patil J (2016) Use of Biomarkers in Tuberculosis Treatment: A Challenging Approach. J Pharmacovigil 4: 1-2.

Patil JS (2015) Novel Tubercular Therapeutic Agents: Need of the Day. Adv Pharmacoepidemiol Drug Saf. 4:e137.

Ali I, Khan AU, Irfan IU (2015) Pharmacovigilance and pharmacists: Need for enhancing role as active health professionals. Archives of Pharmacy Practice 6: 99.

Sri Chandini K (2016) Review on Rosuvastatin. J Pharmacol Toxicol Stu 4: 143-150

Tsoi SC (2016) Adult Neurogenesis in Avian Auditory Cortex, Caudomedial Nidopallium (NCM): Lateralization and Effects of Statins.

Diamond DM, Ravnskov U (2015) How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert review of clinical pharmacology 8: 201-210.